This study indicates that LIG can improve neuron damage in ischemic stroke by promoting mitochondrial autophagy through PINK1/Parkin, and targeting PINK1/Parkin-mediated mitochondrial autophagy and LIG therapy may be a promising therapeutic strategy for ischemic stroke. This evidence concerns the gene PRKN and ischemic stroke.